What is Algorithmic Biologics?
Algorithmic Biologics, established in 2020 and based in Bengaluru, India, operates at the forefront of molecular technology development. The company leverages advanced computational and biological methodologies to innovate within the life sciences sector. Its focus on developing novel molecular solutions positions it as a key player in a rapidly evolving industry, aiming to address complex challenges through cutting-edge scientific advancements.
How much funding has Algorithmic Biologics raised?
Algorithmic Biologics has raised a total of $2.5M across 1 funding round:
Series A
$2.5M
Series A (2024): $2.5M with participation from Bharat Innovation Fund and Axilor Ventures
Key Investors in Algorithmic Biologics
Bharat Innovation Fund
Bharat Innovation Fund is a venture capital firm specializing in early-stage, deep-tech, and intellectual property ventures, based in Bengaluru, India.
Axilor Ventures
Axilor Ventures is an accelerator and seed fund platform that supports early-stage startups, founded by prominent entrepreneurs and business leaders.
What's next for Algorithmic Biologics?
With this substantial Series A financing, Algorithmic Biologics is strategically positioned to expand its research and development capabilities, scale its operations, and potentially broaden its market reach. The investment is expected to fuel further innovation in molecular technology, enabling the company to translate its scientific breakthroughs into tangible products or services. Future endeavors will likely involve strengthening its intellectual property portfolio and forging strategic partnerships to solidify its competitive advantage in the global biotechnology landscape.
See full Algorithmic Biologics company page
